Close Menu

cell-based assays

NEW YORK (GenomeWeb News) – Private equity group Argos Soditic and management members of Cisbio Bioassays today announced that they have acquired Cisbio Bioassays from IBA for an undisclosed amount.
As a result, Cisbio will operate as an independent company.

NEW YORK (GenomeWeb News) – Sanford-Burhnam Medical research Institute said today it has received a grant from the US Department of the Air Force to use cell-based assays to study the potential toxicity of large collections of chemicals.

STOCKHOLM – When Attana, an 11-year-old Swedish biosensor company, introduced its Cell 200 system two years ago, it envisioned a future where its revenues would be driven by instrument placements and consumables sales.

NEW YORK (GenomeWeb News) – Taconic and Medicyte announced a sales and marketing agreement covering Medicyte's products.

NEW YORK (GenomeWeb News) – Researchers from Seattle's Sage Bionetworks, the University of Chicago, the Children's Hospital Oakland Research Institute, and elsewhere reported today that they have detected a new cholesterol-related locus with apparent ties to the risk of muscle-related side effect

NEW YORK (GenomeWeb News) – Evotec and the Jain Foundation today said they have extended and expanded their 2012 research collaboration aimed at dysferlinopathy.
Terms of the expanded deal were not disclosed.

Researchers from the Greenwood Genetic Center have reported positive results that confirm their earlier findings in an effort to develop a test for autism spectrum disorders using Biolog's phenotype array technology.

NEW YORK (GenomeWeb News) – Screening technology firm IntelliCyt today said it raised $8 million in a financing round.
New investor Arboretum Ventures led the financing and was joined by existing investors Prolog Ventures, Verge Fund, and New Mexico Community Capital.

NEW YORK (GenomeWeb News) – VistaGen Therapeutics, a developer of bioassays for drug rescue projects, has signed a strategic financing agreement that will bring in proceeds of $36 million.

NEW YORK (GenomeWeb News) – Bioanalytical tools company Hurel raised $9.2 million in a Series A private equity financing round, the North Brunswick, NJ-based company said today.

Pages

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.